TransMedics Group, Inc. Cash
TransMedics Group, Inc. (TMDX) had Cash of $472.68 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-04
- 2026-06-30: Cash $472.68M.
- 2026-03-31: Cash $461.74M.
- 2025-12-31: Cash $488.37M.
- 2025-09-30: Cash $466.17M.
| Period end | Cash |
|---|---|
| 2026-06-30 | $472.68M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $461.74M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $488.37M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $466.17M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $400.57M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $310.14M 10-Q · filed 2026-05-05 |
| 2024-12-31 | $336.65M 10-K · filed 2026-02-24 |
| 2024-09-30 | $330.09M 10-Q · filed 2025-10-29 |
| 2024-06-30 | $362.75M 10-Q · filed 2025-07-30 |
| 2024-03-31 | $350.22M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $394.81M 10-K · filed 2026-02-24 |
| 2023-09-30 | $427.11M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $582.21M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $195.38M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $201.18M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |